| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Biomarker discovery by mass spectrometry symposium, May 18–19, 2006
|
Bischoff, R.
|
|
2007
|
847 |
1 |
p. 1-2
2 p.
|
article
|
| 2 |
Depletion of high-abundance proteins from serum by immunoaffinity chromatography: A MALDI-FT-MS study
|
Dekker, Lennard J.
|
|
2007
|
847 |
1 |
p. 65-69
5 p.
|
article
|
| 3 |
Direct on-membrane peptide mass fingerprinting with MALDI–MS of tyrosine-phosphorylated proteins detected by immunostaining
|
Nakanishi, Tsuyoshi
|
|
2007
|
847 |
1 |
p. 24-29
6 p.
|
article
|
| 4 |
Editorial Board
|
|
|
2007
|
847 |
1 |
p. iii-
1 p.
|
article
|
| 5 |
FTMS and TOF/TOF mass spectrometry in concert: Identifying peptides with high reliability using matrix prespotted MALDI target plates
|
Dekker, Lennard J.
|
|
2007
|
847 |
1 |
p. 62-64
3 p.
|
article
|
| 6 |
Global and targeted quantitative proteomics for biomarker discovery
|
Veenstra, Timothy D.
|
|
2007
|
847 |
1 |
p. 3-11
9 p.
|
article
|
| 7 |
Improved proteomic discovery by sample pre-fractionation using dual-column ion-exchange high performance liquid chromatography
|
Havugimana, Pierre C.
|
|
2007
|
847 |
1 |
p. 54-61
8 p.
|
article
|
| 8 |
SELDI-TOF mass spectra: A view on sources of variation
|
Dijkstra, Martijn
|
|
2007
|
847 |
1 |
p. 12-23
12 p.
|
article
|
| 9 |
SELDI-TOF-MS of saliva: Methodology and pre-treatment effects
|
Schipper, Raymond
|
|
2007
|
847 |
1 |
p. 45-53
9 p.
|
article
|
| 10 |
Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics
|
West-Nørager, Mikkel
|
|
2007
|
847 |
1 |
p. 30-37
8 p.
|
article
|
| 11 |
Validation of an HIV-1 inactivation protocol that is compatible with intracellular drug analysis by mass spectrometry
|
van Kampen, Jeroen J.A.
|
|
2007
|
847 |
1 |
p. 38-44
7 p.
|
article
|
Journal description